The Deep Digital Phenotyping Lab aims to leverage digital health technologies to identify digital biomarkers for enhanced disease monitoring.
The digitisation of healthcare is transforming the way diseases and populations are characterised and monitored. It enables more personalised healthcare to be provided by taking into account the physiological and contextual specificities of individuals. To move towards precision health, it is necessary to develop innovative approaches that encompass digital, biological, clinical and omics data. All these data would allow for more accurate characterisation of diseases and populations.
I like to work at the interface between digital epidemiology, data science and clinical research. For me the biggest challenge is now to develop innovative approaches where digital data are combined wither other omics, biological and clinical data to deeply characterise the patients.
Guy Fagherazzi, PhD, Group Leader Deep Digital Phenotyping Research Unit, Director, Department of Precision Health